Matches in SemOpenAlex for { <https://semopenalex.org/work/W180696722> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W180696722 abstract "Puma Biotechnology, the new start-up of the founder of Cougar Biotechnology, has in-licensed worldwide development and commercialisation rights to Pfizer’s investigational pan-HER inhibitor neratinib following a pipeline review at the big pharma company. The drug is currently being studied in Phase II and Phase III trials in patients with HER2 (human epidermal growth factor receptor 2)-positive breast cancer and Puma has raised approximately US$55 M in a private placement to help fund its further development." @default.
- W180696722 created "2016-06-24" @default.
- W180696722 creator A5078376245 @default.
- W180696722 date "2011-10-31" @default.
- W180696722 modified "2023-09-28" @default.
- W180696722 title "Pfizer Out-Licenses its Pan-HER Inhibitor Neratinib to Puma Biotechnology" @default.
- W180696722 doi "https://doi.org/10.3833/pdr.v2011i10.1591" @default.
- W180696722 hasPublicationYear "2011" @default.
- W180696722 type Work @default.
- W180696722 sameAs 180696722 @default.
- W180696722 citedByCount "0" @default.
- W180696722 crossrefType "journal-article" @default.
- W180696722 hasAuthorship W180696722A5078376245 @default.
- W180696722 hasConcept C104317684 @default.
- W180696722 hasConcept C121608353 @default.
- W180696722 hasConcept C126322002 @default.
- W180696722 hasConcept C127413603 @default.
- W180696722 hasConcept C144133560 @default.
- W180696722 hasConcept C150903083 @default.
- W180696722 hasConcept C17744445 @default.
- W180696722 hasConcept C199539241 @default.
- W180696722 hasConcept C2777417711 @default.
- W180696722 hasConcept C2779151265 @default.
- W180696722 hasConcept C2779413316 @default.
- W180696722 hasConcept C2779786085 @default.
- W180696722 hasConcept C43521106 @default.
- W180696722 hasConcept C530470458 @default.
- W180696722 hasConcept C54355233 @default.
- W180696722 hasConcept C71924100 @default.
- W180696722 hasConcept C78519656 @default.
- W180696722 hasConcept C86803240 @default.
- W180696722 hasConceptScore W180696722C104317684 @default.
- W180696722 hasConceptScore W180696722C121608353 @default.
- W180696722 hasConceptScore W180696722C126322002 @default.
- W180696722 hasConceptScore W180696722C127413603 @default.
- W180696722 hasConceptScore W180696722C144133560 @default.
- W180696722 hasConceptScore W180696722C150903083 @default.
- W180696722 hasConceptScore W180696722C17744445 @default.
- W180696722 hasConceptScore W180696722C199539241 @default.
- W180696722 hasConceptScore W180696722C2777417711 @default.
- W180696722 hasConceptScore W180696722C2779151265 @default.
- W180696722 hasConceptScore W180696722C2779413316 @default.
- W180696722 hasConceptScore W180696722C2779786085 @default.
- W180696722 hasConceptScore W180696722C43521106 @default.
- W180696722 hasConceptScore W180696722C530470458 @default.
- W180696722 hasConceptScore W180696722C54355233 @default.
- W180696722 hasConceptScore W180696722C71924100 @default.
- W180696722 hasConceptScore W180696722C78519656 @default.
- W180696722 hasConceptScore W180696722C86803240 @default.
- W180696722 hasIssue "10" @default.
- W180696722 hasLocation W1806967221 @default.
- W180696722 hasOpenAccess W180696722 @default.
- W180696722 hasPrimaryLocation W1806967221 @default.
- W180696722 hasRelatedWork W101781971 @default.
- W180696722 hasRelatedWork W2521314248 @default.
- W180696722 hasRelatedWork W2809441278 @default.
- W180696722 hasRelatedWork W3120906260 @default.
- W180696722 hasRelatedWork W73434529 @default.
- W180696722 hasVolume "2011" @default.
- W180696722 isParatext "false" @default.
- W180696722 isRetracted "false" @default.
- W180696722 magId "180696722" @default.
- W180696722 workType "article" @default.